All-New Mitsubishi 2018 Eclipse Cross Offers Stimulating Design, Confidence-Inspiring Driving and Technology to Help “Drive Your Ambition”

With a reputation of being fun to drive and advanced technology, the Eclipse sports car was one of Mitsubishi’s best-selling and iconic vehicles ever. Now, the Eclipse moniker is making its jubilant comeback with the same reputation for driving dynamics and technology in the form of a CUV, the all-new 2018 Eclipse Cross. The Eclipse … Continue reading “All-New Mitsubishi 2018 Eclipse Cross Offers Stimulating Design, Confidence-Inspiring Driving and Technology to Help “Drive Your Ambition””

The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the publication of data from the pivotal Phase III HALO study evaluating the efficacy, safety and tolerability of two subcutaneous dose regimens of fremanezumab for the preventive treatment of chronic migraine (CM). These data were published online today by the New England Journal of Medicine (NEJM) and will appear … Continue reading “The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine”